Please assess the completion status of the following clinical trial:

Trial Title: Effects of URI on Diabetic Subjects Utilizing Technosphere Insulin After a Meal Challenge

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subjects will have met the same inclusion criteria as MKC-TI-030~* Clinical diagnosis of URI with in 24 hrs prior to clinic visit and/or day of clinic visit~* At least 3 URI symptoms~Exclusion Criteria:~* Prior participation in MKC-TI-112~* MedHist, PE or lab findings of acute bacterial infection including but not limited to sputum prod., nasal/eye discharge, chest exam abnormalities, CXR findings of pneumonia.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- 1: TI Inhalation Powder (Type: None): Technosphere® Insulin (TI) Inhalation Powder

Based on this trial design, predict the completion outcome and termination type (if applicable).